| Financial Year |
March 31 2023 |
| Monetary Funds |
455,939,306.43 |
| Held-for-trading Financial Assets |
1,867,900.00 |
| Notes Receivable |
5,264,781.18 |
| Accounts Receivable |
166,631,205.49 |
| Advances to Suppliers |
165,005,028.21 |
| Other Receivables |
2,206,133,876.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
631,647,561.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
123,156,542.91 |
| Total Current Assets |
3,755,646,201.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,139,518.06 |
| Investment Properties |
-- |
| Fixed Assetes |
1,539,515,611.18 |
| Under-construction Projects |
454,671,029.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,557,761,537.71 |
| R&D expenses |
-- |
| Goodwill |
29,744,426.10 |
| Long-Term Deferred and Prepaid Expenses |
2,746,095.18 |
| Deferred Income Tax Assets |
7,456,127.53 |
| Other Non-Current Assets |
72,257,073.23 |
| Sub-Total of Non-Current Assets |
3,767,408,919.86 |
| Total Assets |
7,523,055,121.49 |
| Short-Term Loans |
754,033,622.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
69,999,999.00 |
| Accounts Payable |
293,130,550.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,454,464.15 |
| Taxes Payable |
52,775,268.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
356,912,208.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
91,449,274.26 |
| Other Current Liabilities |
15,092,796.71 |
| Sub-Total of Current Liabilities |
1,769,268,416.63 |
| Long-term Loans |
165,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,357,902.54 |
| Deferred Income Tax Liabilities |
31,399,207.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
231,912,481.27 |
| Total Liabilities |
2,001,180,897.90 |
| Paid-In Capital(Or Share Stock) |
780,781,962.00 |
| Capital Surplus |
2,096,759,135.52 |
| Surplus Reserve |
217,101,719.91 |
| LESS:Treasury Stock |
65,557,586.07 |
| Undistributed Profits |
1,817,149,010.63 |
| Minority Stockholder's Interest |
673,908,524.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,847,965,698.63 |
| Owner's Equity（Stockholder's Equity） |
5,521,874,223.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,523,055,121.49 |
